A carregar...

Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer

OBJECTIVE: Treatment options for metastatic castration resistant prostate cancer (mCRPC) have expanded rapidly in recent years. Given the significant economic burden, we sought perform a cost-effectiveness analysis (CEA) of the contemporary treatment paradigm for mCRPC. METHODS: We devised a treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian J Urol
Main Authors: Pollard, Matthew E., Moskowitz, Alan J., Diefenbach, Michael A., Hall, Simon J.
Formato: Artigo
Idioma:Inglês
Publicado em: Second Military Medical University 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5730904/
https://ncbi.nlm.nih.gov/pubmed/29264205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2016.11.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!